AI data processing time for one imaging exam after deployment.
International Deployment
Parkway Radiology brings SenseCare lung screening into Singapore's clinical workflow.
SenseCare's chest CT intelligence entered IHH Healthcare's Singapore workflow, reducing single-exam data processing to 2-3 minutes while supporting lung nodule screening and follow-up comparison.
Case Summary
Parkway / IHH Healthcare Singapore
Parkway Radiology, part of IHH Healthcare Singapore, deployed SenseCare chest CT intelligence for AI-assisted lung screening and follow-up management. The system entered operation in 2024 after earlier Singapore HSA registration, helping radiologists process high-volume lung nodule screening and follow-up work with quantified indicators, longitudinal comparison and faster report workflows.
Stable monthly AI-assisted examination volume after launch.
Product usage after clinical workflow integration.
AI-assisted reporting efficiency improvement.
SenseCare received Singapore HSA registration for AI-assisted chest CT diagnosis in 2022, laying the compliance foundation for local deployment.
The system was formally deployed within the IHH Healthcare system in 2024 and became part of Parkway Radiology's daily workflow.
The project was selected as the only healthcare case in the China AI global cooperation case collection released at WAIC 2025.
AI reduced data processing time for a single imaging exam to within 2-3 minutes.
After launch, monthly AI-assisted exam volume remained above 2,500, with more than 50 daily active users and usage above 85%.
The system improved pulmonary nodule detection by 11% and AI-assisted report efficiency by 27%.
A gateway case for international medical AI
Parkway Radiology gives SenseCare a demanding international clinical setting: a private healthcare system with strict product, compliance and workflow requirements. SenseCare received Singapore HSA registration for AI-assisted chest CT diagnosis in 2022, and the system entered operation within IHH Healthcare in 2024.
The collaboration shows how Chinese medical AI can enter global healthcare through a disciplined pathway: regulatory registration, local clinical validation, workflow integration, physician acceptance and measurable clinical utility.
AI lung screening for real follow-up work
In lung screening, the system detects millimeter-sized pulmonary nodules from CT images, highlights risk signals and supports follow-up assessment. It can compare imaging across different time points and automatically calculate indicators such as nodule diameter, density and growth rate.
For Parkway Radiology, this reduces repetitive measurement and comparison work. AI brings single-exam data processing down to 2-3 minutes; after launch, monthly AI-assisted exam volume remained above 2,500, with more than 50 daily active users and usage above 85%.
For patients, faster image analysis and more consistent longitudinal comparison can support earlier intervention, clearer risk management and a better diagnostic experience.
A reference for global localization
The Parkway case is not only a product export. It is a localization case across regulation, clinical standards and hospital workflow. Its selection as the only healthcare case in the China AI global cooperation case collection released at WAIC 2025 gives the deployment an additional public evidence signal.
SenseCare's international deployment path now covers product quality, clinical reliability, data governance and operational support.
This makes Parkway a representative customer for SenseCare's overseas strategy, especially for high-standard medical systems in Singapore and Southeast Asia.
Related Products